COMMUNIQUÉS West-GlobeNewswire

Completion of $25 million Subscription
10/01/2019
Summit Therapeutics plc (“Summit Therapeutics” or the “Company”) Completion of $25 million subscription Oxford, UK, and Cambridge, MA, US, 10 January 2019 - Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a leader in [...]
First Asian patient has been included in the global Phase III program for PledOx® and will trigger a milestone payment of 600 MJPY (c.49 MSEK) to PledPharma
10/01/2019
Stockholm, January 10, 2019. PledPharma AB (publ) and Solasia Pharma K.K. announces that the first patient has been included in the global Phase III program for the drug candidate PledOx ® in Japan. This constitutes an [...]
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investment today
10/01/2019
Amsterdam, The Netherlands - 10 January 2019 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a 24 th Tranche of EUR 230,000 is issued as a private placement of 23 convertible notes (the " [...]
Innate Pharma announces its financial calendar for 2019
10/01/2019
INNATE PHARMA ANNOUNCES ITS FINANCIAL CALENDAR FOR 2019 Marseille, France, January 10, 2019, 7:00 AM CET Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces its financial calendar for [...]
Innate Pharma annonce son calendrier financier pour 2019
10/01/2019
INNATE PHARMA ANNONCE SON CALENDRIER FINANCIER POUR 2019 Marseille, le 10 janvier 2019, 7h00 CET Innate Pharma SA (la « Société », Euronext Paris : FR0010331421 – IPH) annonce aujourd’hui son calendrier financier pour l [...]
Cancer Genetics, Inc. Announces Pricing of Public Offering of Common Stock
10/01/2019
RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]
New England Journal of Medicine publishes positive results of the pivotal trial of Cablivi® (caplacizumab) for rare blood clotting disorder
09/01/2019
New England Journal of Medicine publishes positive results of the pivotal trial of Cablivi ® (caplacizumab) for rare blood clotting disorder HERCULES Phase 3 trial met its primary endpoint, demonstrating that treatment [...]
Le New England Journal of Medicine publie les résultats positifs de l'essai pivot du Cablivi® (caplacizumab) dans le traitement d'un trouble rare de la coagulation sanguine
09/01/2019
Le New England Journal of Medicine publie les résultats positifs de l'essai pivot du Cablivi ® (caplacizumab) dans le traitement d'un trouble rare de la coagulation sanguine L'essai HERCULES de phase III a atteint son [...]
DiaMedica Therapeutics Announces Voluntary Delisting from TSX Venture Exchange
09/01/2019
MINNEAPOLIS, Jan. 09, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) (TSX-V: DMA), a clinical stage biopharmaceutical company, announced today that it has applied to voluntarily delist its voting [...]
Imagin Medical Posts New Presentation on Its Website
09/01/2019
VANCOUVER, British Columbia and BOSTON, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that, ahead of its [...]
Loop Industries Reports Third Quarter of Fiscal 2019 Consolidated Results and Achieves Significant Milestones as It Approaches Commercialization
09/01/2019
Announced multi-year supply agreement with PepsiCo Inc. Announced multi-year supply framework with Coca-Cola system’s Cross Enterprise Procurement Group Announced joint venture with Indorama Ventures Public Company [...]
Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
09/01/2019
RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]
Nature Medicine Publishes Local and International Companies’ Major Data Analytics Study of Type 2 Diabetes
09/01/2019
Findings are the result of a year-long collaboration of Roche Diabetes Care GmbH, IBM, Eli Lilly and Company, the Regenstrief Institute and the Indiana Bioscience Research Institute INDIANAPOLIS, Jan. 09, 2019 (GLOBE [...]
UPDATED RELEASE: Rafael Pharmaceuticals Announces Initiation of Patient Enrollment for Phase II Clinical Trial of CPI-613 for Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia
09/01/2019
This release was originally published on January 8th. The updated release makes note that the trial will be led by Ariella Noy, MD at Memorial Sloan Kettering. Newark, NJ, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Rafael [...]
UPDATE -- Dr. Jeffrey D. Gross of Newport Beach, CA Now Offering Virtual Second Opinion Consultations for Surgery
09/01/2019
NEWPORT BEACH, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Dr. Jeffrey D. Gross, a board-certified neurological surgeon, today announced he is now offering comprehensive second opinion consultations for patients [...]
Holding(s) in Company
09/01/2019
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]
Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare
09/01/2019
Program Celebrates the Legacy of Medtronic Co-Founder Earl Bakken and Other Outstanding Patient Advocates Around the World MINNEAPOLIS and Kona, Hawaii - January 9, 2019 - The Medtronic Foundation today announced 12 [...]
Results-Based Outsourcing Inc., Announces Name Change to Driven Inc.
09/01/2019
Company provides update on Capitalization Structure SAN DIEGO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Results Based Outsourcing Inc. (RBOS) today announced that it has received approval for plans to change the corporate name [...]
Intuitive Surgical Announces Preliminary Fourth Quarter and Full Year 2018 Results
09/01/2019
SUNNYVALE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (“Intuitive”) (Nasdaq: ISRG), the pioneer and a global technology leader in robotic-assisted, minimally invasive surgery, today announced [...]

Pages